TMates vs MEDVi 2026: Which Compounded GLP-1 Provider Wins?
Updated May 2026 · Pricing verified directly from provider sites and Trustpilot/BBB filings
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.
Pick TMates if:
You want predictable flat pricing as you titrate up to higher doses, you are willing to commit to a 12-month plan for the lowest monthly rate, you do not need bundled coaching, and you weight regulatory cleanliness — TMates has not received any FDA warning letters.
See TMates PricingPick MEDVi if:
You value the larger Trustpilot review base as a signal of operational maturity, you want bundled 1:1 coaching, or you prefer to evaluate the program for one month at intro pricing before committing further. MEDVi has stronger marketing and onboarding despite the FDA warning.
See MEDVi PricingSide-by-Side Comparison
| Factor | TMates | MEDVi |
|---|---|---|
| Compounded Semaglutide | $158–$249/mo (flat across doses) | $179 first / $299/mo ongoing |
| Compounded Tirzepatide | $167–$297/mo (flat across doses) | $279–$499/mo (dose-dependent) |
| 503A Pharmacy | U.S. 503A (specific partner not publicly disclosed) | Licensed U.S. partners; received FDA misbranding warning Feb 2026 |
| Trustpilot | 3.2/5 (low review volume) | 4.4/5 across 13K+ reviews (efficacy/billing complaints noted) |
| Cancel Policy | Cancel anytime, no contract | Cancel anytime, no contract |
| Pricing Model | Same flat price across all doses (rare in industry) | Tiered pricing + 1:1 coaching included + heavy marketing presence |
Where MEDVi Beats TMates
- Larger Trustpilot review volume (13K+ reviews at 4.4/5) signaling operational maturity.
- 1:1 health coaching included in plans — TMates is medication-only.
- Stronger educational content and onboarding flow for first-time users.
- First-month intro pricing ($179) lets you evaluate before committing.
Where TMates Beats MEDVi
- TMates has avoided the FDA misbranding-warning wave that hit MEDVi in Feb 2026 — cleaner regulatory record.
- TMates flat-dose pricing avoids upcharge surprises; MEDVi tirzepatide can run $499/mo at higher doses.
- TMates 12-month plan is dramatically cheaper than MEDVi ongoing ($158 vs $299 monthly for semaglutide).
- TMates does not bundle coaching into pricing — leaner model for users who do not need or want coaching.
Honest Take: Where TMates Falls Short
MEDVi has 13,000+ Trustpilot reviews vs TMates lower review volume. The MEDVi reviews are mixed — many positive on coaching and ease of use, others negative on oral medication efficacy and billing — but the sheer volume gives MEDVi an operational maturity signal that TMates has not yet matched. TMates is a newer entrant and should be evaluated as such.
Red Flag to Know About MEDVi
February 2026 FDA Warning Letter: MEDVi was among 30+ telehealth firms cited by the FDA for marketing language that implied compounded GLP-1 products were FDA-approved. The warning addressed misbranding, not the underlying medications, but it is a real signal of regulatory friction. MEDVi has updated its marketing to comply.
Related Guides
Continue your research with these related independent reviews.